Sterile Water as control

PreclinicalSmall molecule

TThe University of Texas Health Science Center, Houston

Sterile Water as control is one of 5 small molecule programs targeting Skin. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

SkinNot yet recruiting

SkinPreclinical

Not yet recruiting

Competition

Competitive Landscape

9 competitors in Skin

#DrugCompanyPhaseTrials

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Phase 1

1 2

Litifilimab

Biogen

Phase 1

1 3

Na-ASP-2 Hookworm Vaccine

AAlbert B. Sabin Vaccine Institute

Preclinical

1 4

Sterile Water as control

TThe University of Texas Health Science Center, Houston

Preclinical

1 5

Chlorhexidine-Alcohol

WWashington University School of Medicine

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

N/ANot yet recruiting

Skin

NCT07261527

Clinical

Trials by Indication[1]

Skin1 trial

Characterization of Skin and Facial Fat Pad Thickness Changes Following Microneedling Radiofrequency With and Without Topical Poly-L-Lactic Acid for Facial Rejuvenation

Not yet recruiting·TThe University of Texas Health Science Center, Houston·N/A·NCT07261527·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Sterile Water as control. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sterile Water as control compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Sterile Water as control. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The University of Texas Health Science Center, Houston company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TThe University of Texas Health Science Center, Houston

Sterile Water as control

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Skin1 trial

References

Drug Info

Quick Facts

Related News